The effects of Daikenchuto for the tretment of constipation in the patients with cerebrovascular diseases

The effects of Daikenchuto for the tretment of constipation in the patients with cerebrovascular diseases - Daikenchuto improve constipation in the patients with cerebrovascular diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007393

Enrollment

Registered

2012-05-01

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebrovascular diseases with constipation

Interventions

Tsumura Daikenchuto 15g/day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cerebrovasucular diseases Constipation evaluated by RomaIII Constipation over 6 months and usage of anticonstipation drugs

Exclusion criteria

Exclusion criteria: Patients with malignancy Patients with severe liver, heart, and renal diseases Loss of consciousness Patients who have already treated by Daikenchuto

Design outcomes

Primary

Measure	Time frame
Improvement of clinical score of constipation	—

Countries

Japan

Contacts

Public ContactAkiko Kuwabara

Tohoku University Hospital Comprehensive Regional Medical Education Support Department, Kampo Internal Medicine

akiko.kuwabara.d7@tohoku.ac.jp022-717-7507

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026